Dr. Michael Jaglal, MD

NPI: 1417024746
Total Payments
$89,280
2024 Payments
$23,620
Companies
17
Transactions
67
Medicare Patients
1,468
Medicare Billing
$201,659

Payment Breakdown by Category

Consulting$55,346 (62.0%)
Other$25,750 (28.8%)
Travel$6,282 (7.0%)
Food & Beverage$1,725 (1.9%)
Education$178.06 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $55,346 18 62.0%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $22,975 5 25.7%
Travel and Lodging $6,282 16 7.0%
Honoraria $2,775 2 3.1%
Food and Beverage $1,725 23 1.9%
Education $178.06 3 0.2%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $23,573 13 $0 (2022)
Alexion Pharmaceuticals, Inc. $20,128 12 $0 (2024)
SOBI, INC $13,202 8 $0 (2023)
PFIZER INC. $9,523 10 $0 (2024)
GENZYME CORPORATION $9,050 6 $0 (2023)
Janssen Scientific Affairs, LLC $4,360 4 $0 (2024)
Agios Pharmaceuticals, Inc. $2,775 2 $0 (2023)
Alnylam Pharmaceuticals Inc. $2,760 1 $0 (2024)
Janssen Global Services, LLC $2,180 1 $0 (2023)
Janssen Pharmaceuticals, Inc $1,250 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $23,620 17 Alexion Pharmaceuticals, Inc. ($16,128)
2023 $21,161 14 PFIZER INC. ($7,062)
2022 $16,889 13 Sobi, Inc ($10,427)
2021 $1,013 4 GENZYME CORPORATION ($851.00)
2020 $13,326 5 Novartis Pharmaceuticals Corporation ($10,586)
2019 $11,134 10 Novartis Pharmaceuticals Corporation ($10,962)
2017 $2,137 4 PFIZER INC. ($2,137)

All Payment Transactions

67 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
11/29/2024 Janssen Scientific Affairs, LLC Consulting Fee Cash or cash equivalent $953.75 General
11/13/2024 CSL Behring HEMGENIX (Biological) Food and Beverage In-kind items and services $17.92 General
Category: Hematology
10/21/2024 Alexion Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $13,260.00 General
10/21/2024 Alexion Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $728.97 General
10/21/2024 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $74.98 General
10/21/2024 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $69.90 General
10/20/2024 Alexion Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $1,458.10 General
10/20/2024 Alexion Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $303.15 General
09/30/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $125.00 General
Category: Rare Disease
08/22/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $58.60 General
Category: Rare Disease
06/13/2024 Alnylam Pharmaceuticals Inc. GIVLAARI (Drug) Consulting Fee Cash or cash equivalent $2,760.00 General
Category: Genetic Disease
05/15/2024 Janssen Scientific Affairs, LLC Consulting Fee Cash or cash equivalent $1,090.00 General
05/15/2024 Rigel Pharmaceuticals, Inc. Rezlidhia (Drug), Tavalisse Education Cash or cash equivalent $6.11 General
Category: Acute Myeloid Leukemia
04/02/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,250.00 General
Category: Cardiovascular & Metabolism
02/26/2024 Janssen Scientific Affairs, LLC Consulting Fee Cash or cash equivalent $1,090.00 General
01/17/2024 PFIZER INC. OXBRYTA (Drug) Travel and Lodging In-kind items and services $324.04 General
Category: HEMATOLOGY
01/11/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $49.42 General
Category: Rare Disease
12/11/2023 Janssen Scientific Affairs, LLC Consulting Fee Cash or cash equivalent $1,226.25 General
11/10/2023 PFIZER INC. OXBRYTA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,975.00 General
Category: HEMATOLOGY
11/02/2023 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Consulting Fee Cash or cash equivalent $3,900.00 General
Category: Rare Disease
10/07/2023 PFIZER INC. OXBRYTA (Drug) Travel and Lodging In-kind items and services $506.54 General
Category: HEMATOLOGY
10/07/2023 PFIZER INC. OXBRYTA (Drug) Food and Beverage In-kind items and services $223.31 General
Category: HEMATOLOGY
10/07/2023 PFIZER INC. OXBRYTA (Drug) Travel and Lodging In-kind items and services $216.41 General
Category: HEMATOLOGY
10/07/2023 PFIZER INC. OXBRYTA (Drug) Travel and Lodging In-kind items and services $140.96 General
Category: HEMATOLOGY
09/26/2023 Agios Pharmaceuticals, Inc. PYRUKYND (Drug) Honoraria Cash or cash equivalent $832.50 General
Category: Genetically Defined Disease

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 385 676 $139,781 $55,145
2022 6 320 622 $132,519 $53,911
2021 7 382 609 $111,179 $48,796
2020 7 381 634 $106,295 $43,808
Total Patients
1,468
Total Services
2,541
Medicare Billing
$201,659
Procedure Codes
29

All Medicare Procedures & Services

29 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 144 314 $55,700 $22,980 41.3%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 63 66 $26,488 $9,188 34.7%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 63 133 $19,972 $8,490 42.5%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 42 82 $17,588 $7,379 42.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 38 38 $10,258 $3,910 38.1%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 23 23 $6,210 $1,622 26.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 12 20 $3,565 $1,574 44.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 135 327 $55,342 $23,837 43.1%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 71 172 $36,464 $14,016 38.4%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 68 76 $30,248 $11,994 39.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 19 19 $4,881 $1,782 36.5%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 15 15 $4,050 $1,633 40.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 12 13 $1,534 $648.71 42.3%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 76 182 $38,584 $15,119 39.2%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 84 164 $25,227 $13,160 52.2%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 56 75 $11,490 $5,198 45.2%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 45 47 $12,690 $5,168 40.7%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 19 20 $7,960 $3,229 40.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 37 46 $4,548 $2,411 53.0%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 35 40 $3,960 $1,742 44.0%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 15 15 $3,760 $1,669 44.4%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 15 20 $2,960 $1,101 37.2%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 136 308 $47,124 $19,220 40.8%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 63 65 $17,550 $7,439 42.4%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 41 77 $16,324 $6,605 40.5%

About Dr. Michael Jaglal, MD

Dr. Michael Jaglal, MD is a Internal Medicine healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417024746.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Jaglal, MD has received a total of $89,280 in payments from pharmaceutical and medical device companies, with $23,620 received in 2024. These payments were reported across 67 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($55,346).

As a Medicare-enrolled provider, Jaglal has provided services to 1,468 Medicare beneficiaries, totaling 2,541 services with total Medicare billing of $201,659. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Hospitalist, Hematology & Oncology
  • Location Tampa, FL
  • Active Since 11/30/2006
  • Last Updated 06/02/2025
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1417024746

Products in Payments

  • PROMACTA (Drug) $14,770
  • DOPTELET (Drug) $10,427
  • OXBRYTA (Drug) $7,386
  • ADAKVEO (Biological) $6,778
  • ULTOMIRIS (Biological) $4,185
  • CABLIVI (Biological) $3,707
  • Doptelet (Drug) $2,775
  • PYRUKYND (Drug) $2,775
  • GIVLAARI (Drug) $2,760
  • SARCLISA (Biological) $2,403
  • ELIQUIS (Drug) $2,137
  • XARELTO (Drug) $1,250
  • UBRELVY (Drug) $121.15
  • GVOKE HYPOPEN (Drug) $82.41
  • IMBRUVICA (Drug) $76.95
  • XOSPATA (Drug) $40.91
  • MONOFERRIC (Drug) $39.24
  • HEMGENIX (Biological) $17.92
  • Rezlidhia (Drug) $6.11

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Tampa